Abbott Laboratories
SGO:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SGO:ABT
|
US |
|
E
|
Empresa Distribuidora y Comercializadora Norte SA
BCBA:EDN
|
AR |
|
S
|
Sony Group Corp
F:SON1
|
JP |
|
U
|
UPM-Kymmene Oyj
XBER:RPL
|
FI |
|
A
|
Applied Materials Inc
BMV:AMAT
|
US |
|
E
|
Equifax Inc
XBER:EFX
|
US |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 85.42 USD with a low forecast of 72.59 USD and a high forecast of 99.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
85.42
USD
According to Wall Street analysts, the average 1-year price target for ABT is 85.42 USD with a low forecast of 72.59 USD and a high forecast of 99.65 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
